Ipratropium Bromide
This bromide salt of ipratropium is the standard inhaled anticholinergic bronchodilator used for the maintenance treatment of COPD and acute management of asthma. It blocks muscarinic acetylcholine receptors in the lungs to relax airway smooth muscle and reduce secretions. It is also available as a nasal spray for rhinorrhea.
Khối lượng phân tử
412,4000 g/mol
TPSA
46,50 Ų
Lĩnh vực điều trị
Cơ chế tác dụng
Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.
Cấu trúc 2D
Cite this structure
Embed this structure
SMILES
CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2.O.[Br-]
InChI
InChI=1S/C20H30NO3.BrH.H2O/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;;/h4-8,14,16-19,22H,9-13H2,1-3H3;1H;1H2/q+1;;/p-1/t16-,17+,18+,19?,21?;;
Molecular Formula
C20H30BrNO3
HBD / HBA
1 / 4
Liên kết có thể quay
6
Nguyên tử nặng
25
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Câu hỏi thường gặp
This bromide salt of ipratropium is the standard inhaled anticholinergic bronchodilator used for the maintenance treatment of COPD and acute management of asthma. It blocks muscarinic acetylcholine receptors in the lungs to relax airway smooth muscle and reduce secretions. It is also available as a nasal spray for rhinorrhea.
Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.
Yes, Ipratropium Bromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2134724. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 657308. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="ipratropium-bromide"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/ipratropium-bromide/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/ipratropium-bromide/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/ipratropium-bromide/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="ipratropium-bromide"></drugfyi-drug>